1Department of Biological Chemistry, Merck Research Laboratories, West Point, PA 19486, USA.
Novel HIV-1 therapies targeting viral entry, integration, and assembly offer new options for long-term suppression. Recent preclinical advances highlight promising antiretroviral agents for treating HIV-1 infection.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: